Adiponectin regulation of stellate cell activation via PPARγ- dependent and -independent mechanisms

American Journal of Pathology

Volumn 178, Issue 6, 2011, Pages 2690-2699

  Shafiei, Mahnoush S ^a   Shetty, Shoba ^a   Scherer, Philipp E ^a   Rockey, Don C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; FIBROGENESIS; FIBROSIS; GENE OVEREXPRESSION; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL; WILD TYPE;

EID: 79959439461     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.02.035     Document Type: Article

References (39)

1. Kamada Y, Takehara T, Hayashi N: Adipocytokines and liver disease. J Gastroenterol 2008, 43:811-822
2. Rombouts K, Marra F: Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. Dig Dis 2010, 28:229-235
3. Farrell GC, Larter CZ: Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006, 43:S99-S112
4. Friedman SL, Rockey DC, Bissell DM: Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. Hepatology 2007, 45:242-249
5. Tsukamoto H, She H, Hazra S, Cheng J, Miyahara T: Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation. J Gastroenterol Hepatol 2006, 21 Suppl 3:S102-S105 (Pubitemid 44266562)
6. She H, Xiong S, Hazra S, Tsukamoto H: Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem 2005, 280:4959-4967 (Pubitemid 40288671)
7. Yoneda M, Iwasaki T, Fujita K, Kirikoshi H, Inamori M, Nozaki Y, Maeyama S, Wada K, Saito S, Terauchi Y, Nakajima A: Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue. Alcohol Clin Exp Res 2007, 31(1 Suppl):S15-S21
8. Wang J, Brymora J, George J: Roles of adipokines in liver injury and fibrosis. Expert Rev Gastroenterol Hepatol 2008, 2:47-57
9. Shetty S, Kusminski CM, Scherer PE: Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci 2009, 30:234-239
10. Asano T, Watanabe K, Kubota N, Gunji T, Omata M, Kadowaki T, Ohnishi S: Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis. J Gastroenterol Hepatol 2009, 24:1669-1676
11. Fukushima J, Kamada Y, Matsumoto H, Yoshida Y, Ezaki H, Takemura T, Saji Y, Igura T, Tsutsui S, Kihara S, Funahashi T, Shimomura I, Tamura S, Kiso S, Hayashi N: Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization. Hepatol Res 2009, 39:724-738
12. Arvaniti VA, Thomopoulos KC, Tsamandas A, Makri M, Psyrogiannis A, Vafiadis G, Assimakopoulos SF, Labropoulou-Karatza C: Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis. Acta Gastroenterol Belg 2008, 71:355-360
13. Nakayama H, Otabe S, Yuan X, Ueno T, Hirota N, Fukutani T, Wada N, Hashinaga T, Yamada K: Effects of adiponectin transgenic expression in liver of nonalcoholic steatohepatitis model mice. Metabolism 2009, 58:901-908
14. Ma H, Gomez V, Lu L, Yang X, Wu X, Xiao SY: Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2009, 24: 233-237
15. Nannipieri M, Cecchetti F, Anselmino M, Mancini E, Marchetti G, Bonotti A, Baldi S, Solito B, Giannetti M, Pinchera A, Santini F, Ferrannini E: Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis. Obes Surg 2009, 19:467-474
16. Ding X, Saxena NK, Lin S, Xu A, Srinivasan S, Anania FA: The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol 2005, 166:1655-1669 (Pubitemid 40734389)
17. Hazra S, Xiong S, Wang J, Rippe RA, Krishna V, Chatterjee K, Tsukamoto H: Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem 2004, 279:11392-11401 (Pubitemid 38401638)
18. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, Pang Z, Chen AS, Ruderman NB, Chen H, Rossetti L, Scherer PE: Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 2006, 281:2654-2660 (Pubitemid 43845727)
19. Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, Nawrocki AR, Rajala MW, Parlow AF, Cheeseboro L, Ding YY, Russell RG, Lindemann D, Hartley A, Baker GR, Obici S, Deshaies Y, Ludgate M, Rossetti L, Scherer PE: A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004, 145: 367-383 (Pubitemid 38094532)
20. Wu JB, Chuang HR, Yang LC, Lin WC: A standardized aqueous extract of Anoectochilus formosanus ameliorated thioacetamide-induced liver fibrosis in mice: the role of Kupffer cells. Biosci Biotechnol Biochem 2010, 74:781-787
21. He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM: Adipose-specific peroxisome proliferatoractivated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA 2003, 100:15712-15717 (Pubitemid 38021055)
22. Rockey DC, Chung JJ: Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. J Clin Invest 1996, 98:1381-1388 (Pubitemid 26322063)
23. Shafiei MS, Rockey DC: The role of integrin-linked kinase in liver wound healing. J Biol Chem 2006, 281:24863-24872 (Pubitemid 44274258)
24. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1:431-435 (Pubitemid 12218164)
25. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, Fukui K, Maeda N, Nishizawa H, Nagaretani H, Okamoto Y, Kihara S, Miyagawa J, Shinomura Y, Funahashi T, Matsuzawa Y: Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003, 125:1796-1807 (Pubitemid 37500444)
26. Hellemans K, Michalik L, Dittie A, Knorr A, Rombouts K, De Jong J, Heirman C, Quartier E, Schuit F, Wahli W, Geerts A: Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology 2003, 124:184-201 (Pubitemid 36055351)
27. Yang L, Chan CC, Kwon OS, Liu S, McGhee J, Stimpson SA, Chen LZ, Harrington WW, Symonds WT, Rockey DC: Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2006, 291:G902-G911 (Pubitemid 44772017)
28. Da Silva Morais A, Abarca-Quinones J, Horsmans Y, Stärkel P, Leclercq IA: Peroxisome proliferated-activated receptor gamma ligand, pioglitazone, does not prevent hepatic fibrosis in mice. Int J Mol Med 2007, 19:105-112
29. Adachi M, Brenner DA: High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase. Hepatology 2008, 47:677-685 (Pubitemid 351280736)
30. Asterholm IW, Scherer PE: Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol 2010, 176:1364-1376
31. Zhou M, Xu A, Tam PK, Lam KS, Chan L, Hoo RL, Liu J, Chow KH, Wang Y: Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury. Hepatology 2008, 48:1087-1096
32. Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA: Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice, Hepatology 2002, 35:762-771. (Pubitemid 34258369)
33. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE: Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007, 117:2621-2637 (Pubitemid 47494363)
34. Kamada Y, Yoshida Y, Saji Y, Fukushima J, Tamura S, Kiso S, Hayashi N: Transplantation of basic fibroblast growth factor-pretreated adipose tissue-derived stromal cells enhances regression of liver fibrosis in mice. Am J Physiol Gastrointest Liver Physiol 2009, 296:G157-G167
35. Hautekeete ML, Dodeman I, Azais-Braesco V, Van den Berg K, Seynaeve C, Geerts A: Hepatic stellate cells and liver retinoid content in alcoholic liver disease in humans. Alcohol Clin Exp Res 1998, 22:494-500 (Pubitemid 28208973)
36. Halberg N, Schraw TD, Wang ZV, Kim JY, Yi J, Hamilton MP, Luby-Phelps K, Scherer PE: Systemic fate of the adipocyte-derived factor adiponectin. Diabetes 2009, 58:1961-1970
37. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, Zhang BB, Bonaldo P, Chua S, Scherer PE: Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 2009, 29: 1575-1591
38. Keophiphath M, Achard V, Henegar C, Rouault C, Clément K, Lacasa D: Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol 2009, 23:11-24
39. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE: Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 2009, 29:4467-4483